AI Medical Compendium Journal:
European journal of pharmacology

Showing 1 to 10 of 12 articles

Single-cell omics: moving towards a new era in ischemic stroke research.

European journal of pharmacology
Ischemic stroke (IS) is a highly complex and heterogeneous disease involving multiple pathophysiological events. A better understanding of the pathophysiology of IS will enhance preventive, diagnostic and therapeutic strategies. Despite significant a...

AI in action: Changes to student perceptions when using generative artificial intelligence for the creation of a multimedia project-based assessment.

European journal of pharmacology
INTRODUCTION: New modes of assessments are needed to evaluate of the authenticity of student learning in an artificial intelligence (AI) world. In mid-2023, we piloted a new assessment type; a collaborative group multimedia assessment with AI allowan...

A novel neural network-based nearest neighbor approach for drug function prediction from chemical structures.

European journal of pharmacology
Drug function prediction is a crucial task in drug discovery, design, and development, which involves the prediction of the biological functions of a drug molecule based on its chemical structure. Misleading drug function is a common reason for adver...

Machine learning enables high-throughput, low-replicate screening for novel anti-seizure targets and compounds using combined movement and calcium fluorescence in larval zebrafish.

European journal of pharmacology
Identifying new anti-seizure medications (ASMs) is difficult due to limitations in animal-based assays. Zebrafish (Danio rerio) serve as a model for chemical and genetic seizures, but current methods for detecting anti-seizure responses are limited b...

Potential diagnostic biomarkers in heart failure: Suppressed immune-associated genes identified by bioinformatic analysis and machine learning.

European journal of pharmacology
Heart failure (HF) threatens tens of millions of people's health worldwide, which is the terminal stage in the development of majority cardiovascular diseases. Recently, an increasing number of studies have demonstrated that bioinformatics and machin...

Unleashing the future: The revolutionary role of machine learning and artificial intelligence in drug discovery.

European journal of pharmacology
Drug discovery is a complex and multifaceted process aimed at identifying new therapeutic compounds with the potential to treat various diseases. Traditional methods of drug discovery are often time-consuming, expensive, and characterized by low succ...

AI-Based solutions for current challenges in regenerative medicine.

European journal of pharmacology
The emergence of Artificial Intelligence (AI) and its usage in regenerative medicine represents a significant opportunity that holds the promise of tackling critical challenges and improving therapeutic outcomes. This article examines the ways in whi...

Identification of COL3A1 as a candidate protein involved in the crosstalk between obesity and diarrhea using quantitative proteomics and machine learning.

European journal of pharmacology
BACKGROUND: Increasing epidemiologic studies have shown a positive correlation between obesity and chronic diarrhea. Nevertheless, the precise etiology remains uncertain.

Novel drug discovery: Advancing Alzheimer's therapy through machine learning and network pharmacology.

European journal of pharmacology
Alzheimer's disease (AD), marked by tau tangles and amyloid-beta plaques, leads to cognitive decline. Despite extensive research, its complex etiology remains elusive, necessitating new treatments. This study utilized machine learning (ML) to analyze...

Improving chimeric antigen receptor T-cell therapies by using artificial intelligence and internet of things technologies: A narrative review.

European journal of pharmacology
Cancer poses a formidable challenge in the field of medical science, prompting the exploration of innovative and efficient treatment strategies. One revolutionary breakthrough in cancer therapy is Chimeric Antigen Receptor (CAR) T-cell therapy, an av...